Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog
- PMID: 1650296
- DOI: 10.1161/01.res.69.2.332
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog
Abstract
The functional integrity of the beta- and alpha-adrenergic stimulatory pathways in a rapid ventricular pacing model of congestive heart failure in dogs was investigated; normal dogs served as controls. Total beta-adrenergic receptor density was 35% lower (p less than 0.01) in the pacing-overdrive dogs, and the beta-adrenergic receptor-mediated stimulation of adenylate cyclase (Vmax) was found to be 68% and 72% lower (p less than 0.01) in the left and right ventricles of the paced dogs. In addition, the basal adenylate cyclase activity was found to be 56% and 68% lower (p less than 0.01) in the left and right ventricles of the failing heart. Similarly, the Vmax of 5'-guanylylimidodiphosphate (GppNHp) and forskolin stimulation of adenylate cyclase activity was significantly lower, 70% and 55%, respectively (p less than 0.01), in both ventricles of the paced dogs. However, although the concentration yielding half-maximal velocity for beta-agonist and GppNHp stimulation of adenylate cyclase was similar in both groups, that for forskolin stimulation of the enzyme was significantly increased (p less than 0.01). Pertussis toxin-mediated ADP-ribosylation of membranes from control and failing hearts revealed a significant decrease in the inhibitory guanine nucleotide binding protein content (48 +/- 9%, p less than 0.01) in the hearts of the paced dogs. Moreover, although the pertussis toxin treatment increased the basal and the forskolin-stimulated adenylate cyclase activity in both normal and failing heart membranes, the adenylate cyclase activity remained significantly depressed in the failing heart after pertussis toxin treatment (p less than 0.01). Consistent with the depressed adenylate cyclase activity, mechanical studies on isolated papillary muscles and trabeculae revealed a decrease in baseline total tension (from 7.0 +/- 0.7 to 3.8 +/- 0.4 g/mm2, p less than 0.01) and dT/dt (from 26 +/- 8 to 13 +/- 1 g/mm2/sec, p less than 0.01) in the pacing-overdrive model. Tension generation and dT/dt observed in the paced dogs in response to increasing concentrations of forskolin demonstrated a rightward shift in the dose-response curve and a decrease in maximal forskolin stimulation (p less than 0.01). Similarly, maximal tension and dT/dt in the presence of isoproterenol was significantly lower than in the normal dogs (p less than 0.01). The decrease in beta-adrenergic responsiveness was accompanied by a decrease and rightward shift in alpha 1-adrenergic responsiveness (increase in tension was 1.1 +/- 0.1 g/mm2 in paced dogs versus 2.1 +/- 0.1 g/mm2 in controls, p less than 0.01).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.Circulation. 1992 Nov;86(5):1584-95. doi: 10.1161/01.cir.86.5.1584. Circulation. 1992. PMID: 1330362
-
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.Circ Res. 1991 Dec;69(6):1546-56. doi: 10.1161/01.res.69.6.1546. Circ Res. 1991. PMID: 1659503
-
Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.Eur J Pharmacol. 1987 Aug 11;140(2):123-32. doi: 10.1016/0014-2999(87)90798-9. Eur J Pharmacol. 1987. PMID: 2822436
-
[Alterations of the cAMP-adenylate cyclase system in the failing human heart. Consequences for the therapy with inotropic drugs].Klin Wochenschr. 1990 Sep 14;68(18):887-95. doi: 10.1007/BF01649033. Klin Wochenschr. 1990. PMID: 1979643 Review. German.
-
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.Heart Fail Rev. 2010 Sep;15(5):495-512. doi: 10.1007/s10741-010-9183-5. Heart Fail Rev. 2010. PMID: 20658186 Free PMC article. Review.
Cited by
-
DDD-pacing-induced cardiomyopathy following AV node ablation for persistent atrial tachycardia.J Interv Card Electrophysiol. 1999 Dec;3(4):321-3. doi: 10.1023/a:1009879718894. J Interv Card Electrophysiol. 1999. PMID: 10525246
-
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.Mol Cell Biochem. 2000 Nov;214(1-2):131-55. doi: 10.1023/a:1007131925048. Mol Cell Biochem. 2000. PMID: 11195784 Review.
-
Beta-adrenergic receptors in heart failure.J Clin Invest. 1993 Dec;92(6):2564. doi: 10.1172/JCI116867. J Clin Invest. 1993. PMID: 8254011 Free PMC article. Review. No abstract available.
-
Tachycardiomyopathy induced by ventricular premature complexes: complete recovery after radiofrequency catheter ablation.Korean J Intern Med. 2006 Sep;21(3):213-7. doi: 10.3904/kjim.2006.21.3.213. Korean J Intern Med. 2006. PMID: 17017676 Free PMC article.
-
Heart failure and tachycardia-induced cardiomyopathy.Curr Heart Fail Rep. 2013 Dec;10(4):296-306. doi: 10.1007/s11897-013-0150-z. Curr Heart Fail Rep. 2013. PMID: 23963583 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical